AstraZeneca PLC (AZN)
NYSE: AZN · Pharmaceutical Preparations · Cambridge · filing with the SEC since 1995
Who owns AstraZeneca PLC
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 7.6% of Common Stock, as its SCHEDULE 13G/A filed Apr 23, 2025 says.
Directors and officers
1
report now, of 1 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 28, 2026 · Common Stock
What AZN reports owning in othersstakes of 5% or more, and other ties
Cellectis S.A. CLLS
SCHEDULE 13D/A · filed Jan 24, 2025 · Ordinary shares, nominal value of EUR0.05 per ordinary share
Innate Pharma S.A. IPHA
SCHEDULE 13D/A · filed Feb 6, 2026 · Ordinary Shares, EUR0.05 nominal value per share
Monopar Therapeutics Inc. MNPR
SCHEDULE 13G/A · filed Feb 6, 2026 · Common Stock, $0.001 par value per share
CDT Equity Inc. CDT
SCHEDULE 13G/A · filed Apr 10, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
Other ties the annual report names
Acerta Pharma
An entity · subsidiary · owns, named in the 20-F filed Feb 24, 2026
Acerta Pharma Bv
An entity · subsidiary · owns, named in the 20-F filed Feb 24, 2026
SixPeaks Bio Ag
An entity · subsidiary · owns, named in the 20-F filed Feb 24, 2026
All entity's associates and joint ventures
An entity · co registrant · owns, named in the 20-F filed Feb 24, 2026
BMS's share of Global Diabetes Alliance
A company bought · acquisition · owns, named in the 20-F filed Feb 24, 2026
12 subsidiaries in 4 countries, from the list filed with the 20-F filed Feb 24, 2026.
Insider tradesForm 4
1sales
1purchases
0sales on a scheduled plan
1people selling
$2.2Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 1 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Sharma Mani | See remarks | 1 | $2.2M | 0 | 1 | $0 |